Latest Mrna Podcast Episodes
Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations
The Lancet Oncology in conversation with - June 24, 2024 22:00 - 36 minutes ★★★★★ - 1 ratingDr Hisham Mehanna (University of Birmingham, Birmingham, UK) and Dr Sue Yom (University of California, San Francisco, San Francisco, CA, USA) discuss their four-paper Series on Head and Neck Cancer Consensus Recommendations in diagnosis and clinical trial endpoints. Tell us what you thought abo...
Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment
The Lancet Oncology in conversation with - May 28, 2024 22:00 - 24 minutes ★★★★★ - 1 ratingDr Garth Strohbehn (Veteran Affairs Center for Clinical Management Research, Ann Arbor, Michigan, USA) and Dr Katie Lichter (University of California, San Francisco, USA) discuss their papers on the environmental impact of cancer treatments and the public harms resulting from it. Tell us what y...
James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean
The Lancet Oncology in conversation with - April 29, 2024 22:00 - 35 minutes ★★★★★ - 1 ratingDr James Shultz, (University of Miami Miller School of Medicine, Miami, USA), Dr Ana Patricia Ortiz (University of Puerto Rico, and University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico), and Dr Leticia Nogueira (American Cancer Society, Georgia, USA) discuss their Persona...
Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials
The Lancet Oncology in conversation with - April 08, 2024 22:00 - 11 minutes ★★★★★ - 1 ratingDr Bernardo Goulart (US Food and Drug Administration) discusses his paper on correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer. Read the full article: https://www.thelancet.com/journals/lanonc/arti...
Maria Kyrgiou on innovations in gynaecological cancers and global disparities
The Lancet Oncology in conversation with - March 07, 2024 23:00 - 25 minutes ★★★★★ - 1 ratingIn a special episode on International Women's Day 2024, we speak with Dr Maria Kyrgiou (Imperial College London, London, UK) about her Essay on innovations and disparities in gynaecological cancer care. Tell us what you thought about this episode Continue this conversation on social! Follow us...
Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers
The Lancet Oncology in conversation with - February 26, 2024 23:00 - 34 minutes ★★★★★ - 1 ratingDr Georgios Lyratzopoulos (University College London, London, UK) discusses his two papers from the International Cancer Benchmarking Partnership on the use of chemotherapy or radiotherapy in eight common cancers in Norway, the UK, Canada, and Australia. Tell us what you thought about this epis...
Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer
The Lancet Oncology in conversation with - January 29, 2024 23:00 - 16 minutes ★★★★★ - 1 ratingProfessor Mike Sathekge (Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa) discusses his Article entitled, ‘Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre retrospective study.’ Read the full arti...
Shankar Shiva on stereotactic body radiotherapy for primary renal cell carcinoma
The Lancet Oncology in conversation with - January 02, 2024 23:00 - 13 minutes ★★★★★ - 1 ratingSenior Editor Owen Stretton talks to Professor Shankar Shiva from the Peter MacCallum Cancer Centre in Melbourne about the International Society of Stereotactic Radiosurgery’s new systematic review and practice guidelines for stereotactic body radiotherapy in primary renal cell carcinoma. Conti...
Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma
The Lancet Oncology in conversation with - January 02, 2024 23:00 - 13 minutes ★★★★★ - 1 ratingSenior Editor Owen Stretton talks to Professor Shankar Siva from the Peter MacCallum Cancer Centre in Melbourne about the International Society of Stereotactic Radiosurgery’s new systematic review and practice guidelines for stereotactic body radiotherapy in primary renal cell carcinoma. Tell u...
Neerja Bhatla on a new quadrivalent HPV vaccine
The Lancet Oncology in conversation with - November 29, 2023 14:00 - 12 minutes ★★★★★ - 1 ratingProfessor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India. Read ...
Chandra Are on the Lancet Oncology Commission on Global Cancer Surgery
The Lancet Oncology in conversation with - November 01, 2023 23:00 - 43 minutes ★★★★★ - 1 ratingDr Chandra Are (University of Nebraska Medical Center, Omaha, NE, USA) discusses highlights and recommendations from the Lancet Oncology Commission on Global cancer surgery: pragmatic solutions to improve cancer surgery outcomes worldwide. Tell us what you thought about this episode Continue t...
Philipp Karschnia on tissue sampling and processing during resection of diffuse intracranial glioma
The Lancet Oncology in conversation with - October 31, 2023 23:00 - 17 minutes ★★★★★ - 1 ratingDoctor Philipp Karschnia (Ludwig-Maximilians-University of Munich, Munich, Germany) discusses the Response Assessment in Neuro Oncology consortium’s recommendations on standardised tissue sampling and processing during resection of diffuse intracranial glioma. Read the full Policy Review: https...
Wanda Cui on measuring ovarian toxicity
The Lancet Oncology in conversation with - October 03, 2023 09:00 - 10 minutes ★★★★★ - 1 ratingDr. Wanda Cui (Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia) discusses her Review on measuring ovarian toxicity in clinical trials. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00390-X/fulltext?dgcid=buzzsprout_...
Ticiana Leal on Tumour Treating Fields
The Lancet Oncology in conversation with - September 01, 2023 14:00 - 9 minutes ★★★★★ - 1 ratingTiciana Leal (Winship Cancer Institute at Emory University, Atlanta, GA, USA) discusses her paper on Tumour Treating Fields. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00344-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc Tell us what you t...
Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA
The Lancet Oncology in conversation with - August 02, 2023 08:00 - 12 minutes ★★★★★ - 1 ratingXuesong Han (American Cancer Society, Atlanta, GA, USA) discusses her study on changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00293-0/fulltext...
Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma
The Lancet Oncology in conversation with - July 03, 2023 22:00 - 33 minutes ★★★★★ - 1 ratingCarlos Fernández de Larrea (Hospital Clínic de Barcelona, Barcelona, Spain) and Damian Green (Fred Hutch Cancer Center, Seattle, WA, USA) discuss their studies on BCMA CAR T cells in patients with relapsed or refractory multiple myeloma. Read the full article: https://www.thelancet.com/journals...
Madeline Pe on the SISAQOL initiative
The Lancet Oncology in conversation with - May 31, 2023 22:00 - 14 minutes ★★★★★ - 1 ratingMadeline Pe (EORTC, Brussels, Belgium) discusses her Policy Review on the innovative medicines initiative, an expansion of the Setting International Standards in Analysing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials (SISAQOL) initiative. Read the full artic...
Life sciences companies and the risks posed by the mifepristone litigation
At the Intersection of Science and Law - May 19, 2023 15:54 - 33 minutesIn this episode, a cross-disciplinary team of FDA regulatory lawyers and life sciences litigators discuss the implications of the mifepristone litigation for life sciences companies as it pertains to citizen petitions, FDA approvals, and strategies manufacturers might consider going forward. Se...
Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children
The Lancet Oncology in conversation with - May 02, 2023 22:00 - 28 minutes ★★★★★ - 1 ratingDr Kadia Petricca (SickKids Hospital, Toronto, Canada), Dr Joyce Kambugu (Uganda Cancer Institute, Kampala, Uganda), and Dr Avi Denburg (SickKids Hospital) discuss their paper “Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and hea...
Trade secrets protection in the life sciences sector
At the Intersection of Science and Law - April 12, 2023 13:33 - 21 minutesDLA Piper’s Roberto Valenti and Ray Miller discuss trade secrets protection in the US and Europe and the peculiarities within the life sciences sector. Our speakers provide pragmatic approaches and suggestions on how to manage trade secrets for both pharmaceutical companies and medical device ma...
Mark Lythgoe on UK oncology drug approval after Brexit
The Lancet Oncology in conversation with - March 27, 2023 22:00 - 14 minutes ★★★★★ - 1 ratingDr Mark Lythgoe (Imperial College London, London, UK), discusses his new Review, "From The European Medicines Agency to Project Orbis: New activities and challenges to facilitate UK Oncology Drug Approval following Brexit". Tell us what you thought about this episode Continue this conversation...
Janet Brown on the phase 2/3 STAR trial
The Lancet Oncology in conversation with - February 28, 2023 13:00 - 20 minutes ★★★★★ - 1 ratingProf Janet Brown (University of Sheffield, Sheffield, UK) discusses the phase 2/3 STAR trial on treatment cessation versus continuation with tyrosine kinase inhibitors in advanced renal cell carcinoma. Read the full article: Temporary treatment cessation versus continuation of first-line tyrosi...
Cross-border considerations for privacy in clinical trials
At the Intersection of Science and Law - February 06, 2023 16:11 - 18 minutesPublished in Chambers Expert Focus. With the recent publication of our Cross-border Guide to Clinical Trials and Privacy, James Clark, Paula Gonzalez de Castejón and David Kopans discuss ongoing and developing EU and US perspectives on privacy considerations with respect to cross-border clinical...
Valerie Speirs on biomarkers in male breast cancer
The Lancet Oncology in conversation with - January 30, 2023 23:00 - 17 minutes ★★★★★ - 1 ratingProf Valerie Speirs (University of Aberdeen, Aberdeen, Scotland) discusses her Systematic Review on genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers in male breast cancer. Read the full article: Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic bio...
Sameer Bakhshi on sex disparities in childhood cancer in India
The Lancet Oncology in conversation with - January 03, 2023 23:00 - 23 minutes ★★★★★ - 1 ratingProf Sameer Bakhshi, (All India Institute of Medical Sciences, New Delhi, India) discusses his Article on sex disparities in childhood cancer in India. Read the full article: Sex disparity in childhood cancer in India: a multi-centre, individual patient data analysis Tell us what you thought a...
Shankar Siva on radiotherapy for primary renal cell carcinoma
The Lancet Oncology in conversation with - November 28, 2022 23:00 - 8 minutes ★★★★★ - 1 ratingShankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma. Read the full article: 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell...
Mark Lawler and Richard Sullivan on the European Groundshot
The Lancet Oncology in conversation with - November 15, 2022 23:00 - 23 minutes ★★★★★ - 1 ratingMark Lawler (Queen’s University Belfast, Belfast, UK) and Richard Sullivan (Kings College London, London, UK) discuss the European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission. Tell us what you thought about this episode Continue this conversation on ...
Global Life Sciences Supply Chain Insights
At the Intersection of Science and Law - November 03, 2022 17:22 - 27 minutesPublished in Chambers Expert Focus. Lauren Murdza and Richard Taylor share their insights on supply chain issues in the life sciences sector in the latest episode of At the Intersection of Science and Law. See omnystudio.com/listener for privacy information.
Samar Alhomoud on challenges for cancer control in the Gulf region
The Lancet Oncology in conversation with - October 31, 2022 23:00 - 11 minutes ★★★★★ - 1 ratingSamar Alhomoud (King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia) discusses her review on progress and remaining challenges for cancer control in the Gulf Cooperation Council. Read the full article: Progress and remaining challenges for cancer control in the Gulf Cooper...
Inge Marie Svane on mRNA vaccines for cancer treatment
The Lancet Oncology in conversation with - September 27, 2022 09:00 - 8 minutes ★★★★★ - 1 ratingInge Marie Svane (Copenhagen University Hospital, Copenhagen, Denmark) discusses her Review on clinical advances and ongoing trials on mRNA vaccines for cancer treatment. Read the full Review: Clinical advances and ongoing trials on mRNA vaccines for cancer treatment Tell us what you thought a...